Newsletter Archive

  1. 09.11.17 -- Senate Revises Right-To-Try, CUPA Still Gives Thumbs Down
    9/11/2017
    09/11/17 Clinical Leader Newsletter
  2. 09.06.17 -- Do Rare Disease Cures Require A Different Partnering Paradigm?
    9/6/2017
    09/06/17 Clinical Leader Newsletter
  3. 08.30.17 -- Is CRO Consolidation Good For Pharma?
    8/30/2017
    08/30/17 Clinical Leader Newsletter
  4. 08.28.17 -- DIA Trends: Technology, Trial Design, & Regulators
    8/28/2017
    08/28/17 Clinical Leader Newsletter
  5. 08.23.17 -- Use Extension Studies To Enhance Phase 3 Data
    8/23/2017
    08/23/17
  6. 08.21.17 -- 86% Of Americans: Healthcare Workers Should Discuss Clinical Trials
    8/21/2017
    08/21/17 Clinical Leader Newsletter
  7. 08.16.17 -- Should We Rethink Randomized Clinical Trials?
    8/16/2017
    08/16/17 Clinical Leader Newsletter
  8. 08.14.17 -- Bayer Relies On Best Practices To Beat Liver Cancer
    8/14/2017
    08/14/17 Clinical Leader Newsletter
  9. 08.07.17 -- Janssen’s Encouraging HIV Vaccine Trial Results
    8/7/2017
    08/07/17 Clinical Leader Newsletter
  10. 08.02.17 -- 5 Best Practices For Engaging With Patient Advocacy Groups
    8/2/2017
    08/02/17 Clinical Leader Newsletter